Clinical Trial Update: Understanding Poor Vaccine Responses to Hepatitis B Vaccination [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating why some individuals have poor immune responses to the Hepatitis B vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: NYU Langone Health | Conditions: Vaccine Reaction | Phase 4 | Status: ACTIVE_NOT_RECRUITING